RADAR-AD represented at European Commission’s Research and Innovation Days in Brussels

Our researchers presented the work of RADAR-AD at the exhibition “Science is Wonderful!” on the 25th and 26th of September which aimed at bringing science closer to the general public.

“Science is Wonderful!” was part of the Research and Innovation Days organized by the European Commission in Brussels, Belgium. The exhibition targeted everyone passionate about science, research and innovation, ranging from education professionals, researchers, students, school children, the media and the general public. It presented an invaluable opportunity to showcase present scientific research to the public and engage wider audiences with scientific studies. The exhibition spanned a broad variety of EU-funded research projects, from moon rovers to bioplastic and others.

At the event, RADAR-AD was represented by Marijn Muurling, PhD student at the Amsterdam UMC and part of the clinical study, interested in how new technologies can help people with Alzheimer’s disease. Marijn explained the goal, research and methods of RADAR-AD to the attendees. Together with Robbert Harms, a machine learning expert from Altoida Inc., they showed medical devices, such as the Altoida app. This is an app on a tablet which includes a motor task and augmented reality task, which screens people for Alzheimer’s disease in an early stage of the condition. Marijn and Robbert explained how we will use this application within the RADAR-AD study – namely, as a digital biomarker for visuospatial and executive function and spatial memory.

Moreover, attendees had the opportunity to interact with the Mezurio app which measures cognition. They could play several brain training games on it and learn how we apply these within the research done in RADAR-AD. Also, real-time data from a Fitbit was shown, which is used in the RADAR-CNS study as well. RADAR-AD uses this smartwatch to measure sleep, movements and heartbeat during daily life activities. Lastly, a video of a smart home in Greece was shown which presents the idea of a particularly designed home adapting to the needs of an Alzheimer’s diagnosed person and thus supports people living with Alzheimer’s to live more independently. This smart home will be used within the RADAR-AD research as part of a small sub-study (in tier 3).

In addition to school children, researchers and families, representatives from partner and funder organizations also interacted with our team and the devices shown. Among them was Pierre Meulien – Executive Director of the Innovative Medicines Initiative (IMI), which provides funding to RADAR-AD.

Our researchers were happy to receive a positive response to the work done within RADAR-AD. Marijn Muurling shares: “They were all very enthusiastic and curious about the devices and data, especially when they heard that they could play a game.”